Introduction: Hepatocellular carcinoma (HCC) is the fift h most common cancer worldwide. HCC often develops from cirrhosis. There has been an increasing incidence of HCC from NASH-cirrhosis. Moreover, HCC cases have been reported arising... Miao,Pineda 被引量: 46发表: 2012年 Diagnosis and cla...
NO has broad and sometimes dichotomous roles in cancer. The effects of NO in tumours depend on the type and localization of NOS isoforms, concentration and duration of NO exposure, and cellular sensitivity to NO. Hepatocellular carcinoma (HCC) is a common and lethal disease for which no effecti...
doi:10.1002/cld.1003Renumathy DhanasekaranDivision of Gastroenterology and Hepatology Stanford University Palo Alto CAPaul Y. KwoDivision of Gastroenterology and Hepatology Stanford University Palo Alto CAJohn Wiley & Sons, LtdClinical Liver Disease...
Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world. Most patients still present late in the course of the disease so that curative therapy is rarely possible. Strategies developed to improve the prognosis include primary prevention, directed at the underlying liver diseases,...
and its expression is associated with more advanced HCC stage and shorter disease-free survival. SCD1 promotes liver cancer stemness through the synthesis of MUFAs, which can stabilise β-catenin, thereby inducing Wnt/β-catenin signalling, as well as generating a feed-forward loop to elevate SCD...
Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic inflammatory diseasesof the liver, which can be transmitted to steatohepatitis, which in about 20% progresses to cirrhosisor liver cancer. It is a multifactorial... P Turčić,Ž Maleš 被引量: 0发表: 2017年...
leukemia and breast cancer by metabolic rewiring20,21. SCARB2 acts as a receptor in the pathogenesis of hand, foot and mouth disease22. Moreover, it functions as a phospholipid receptor23and is involved in lysosomal cholesterol export17. However, the role of SCARB2 in cancer, especially HCC,...
7.A new target in future treatment of liver cancer-liver cancer stem cells未来肝癌治疗的新靶点-肝癌干细胞 8.Intracellular Expression of Anti Hepatocellular Carcinoma (HCC) Single Chain Antibody (scFv) in HCC Cell Line;细胞内表达抗肝癌单链抗体对肝癌细胞的作用 9.The Expression of STAT 5 in huma...
Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma. Arch. Pharmacal. Res. 42, 48–62. https://doi.org/10.1007/s12272-018-01104-x (2019). Article CAS Google Scholar Chan, J. J. & Tay, Y. Noncoding RNA:RNA regulatory networks in cancer. Int. J. Mol....
Hepatocellular carcinoma is the third leading cause of deaths from cancer worldwide. Infection with the hepatitis B virus is one of the leading risk factors for developing hepatocellular carcinoma, particularly in East Asia1. Although surgical treatment may be effective in the early stages, the five...